Hydroxysafflor Yellow A Attenuates Myocardial Ischemia/Reperfusion Injury-induced Platelet Activation: Role of Mitochondrial Function andAutophagy

INTRODUCTION: Platelet activation is a key contributor to myocardial ischemia/ reperfusion (MI/R) injury. Although hydroxysafflor yellow A (HSYA) possesses cardioprotective and antiplatelet properties, its specific mechanisms in modulating platelet activation during MI/R remain unclear. OBJECTIVES: This study investigated how HSYA attenuates MI/R injury by regulating platelet activation. METHODS: An MI/R model was established in mice via ligation of the left anterior descending coronary artery. The regulatory effects of HSYA on platelet activation and mitochondrial function were evaluated via flow cytometry. The mechanisms were analyzed via platelet proteomics. Platelet autophagy was characterized via transmission electron microscopy and western blotting. RESULTS: HSYA significantly attenuated MI/R injury by reducing the myocardial infarct size, improving cardiac function, and decreasing platelet accumulation in the myocardium. HSYA also suppressed platelet activation and enhanced platelet mitochondrial function. Platelet proteomic analysis indicated that the beneficial effects of HSYA were associated primarily with the modulation of proteins involved in energy metabolism and autophagy pathways. Furthermore, HSYA was found to regulate platelet autophagy, as evidenced by both a change in the number of autophagosomes and altered expression of key autophagy-related proteins, including ATG4A, GLIPR2, P62, and LC3. DISCUSSION: Our study provides novel mechanistic insights into how HSYA confers cardioprotection against MI/R injury, highlighting its clinical potential by demonstrating that its effects are mediated at least in part through the modulation of platelet energy metabolism and autophagy. CONCLUSION: HSYA alleviates MI/R injury by inhibiting platelet activation, which is associated with the restoration of mitochondrial function and the modulation of autophagy in platelets.

Authors

Institutions

Publication Details

Journal
Current Pharmaceutical Biotechnology
Published
2026-04-21
DOI
https://doi.org/10.2174/0113892010470039260325123335
Primary Topic
Sunflower and Safflower Cultivation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hydroxysafflor Yellow A Attenuates Myocardial Ischemia/Reperfusion Injury-induced Platelet Activation: Role of Mitochondrial Function andAutophagy

G Y Sun, Zi Wang, Yaqi Zhang, Ruotong Li et al.
Current Pharmaceutical Biotechnology
Sunflower and Safflower Cultivation
article

Hydroxysafflor Yellow A Attenuates Myocardial Ischemia/Reperfusion Injury-induced Platelet Activation: Role of Mitochondrial Function andAutophagy

G Y Sun, Zi Wang, Yaqi Zhang, Ruotong Li, Rui Zhang, Zhiwei Liu, Ruoyun Li, Min Wang
article en

Abstract

INTRODUCTION: Platelet activation is a key contributor to myocardial ischemia/ reperfusion (MI/R) injury. Although hydroxysafflor yellow A (HSYA) possesses cardioprotective and antiplatelet properties, its specific mechanisms in modulating platelet activation during MI/R remain unclear. OBJECTIVES: This study investigated how HSYA attenuates MI/R injury by regulating platelet activation. METHODS: An MI/R model was established in mice via ligation of the left anterior descending coronary artery. The regulatory effects of HSYA on platelet activation and mitochondrial function were evaluated via flow cytometry. The mechanisms were analyzed via platelet proteomics. Platelet autophagy was characterized via transmission electron microscopy and western blotting. RESULTS: HSYA significantly attenuated MI/R injury by reducing the myocardial infarct size, improving cardiac function, and decreasing platelet accumulation in the myocardium. HSYA also suppressed platelet activation and enhanced platelet mitochondrial function. Platelet proteomic analysis indicated that the beneficial effects of HSYA were associated primarily with the modulation of proteins involved in energy metabolism and autophagy pathways. Furthermore, HSYA was found to regulate platelet autophagy, as evidenced by both a change in the number of autophagosomes and altered expression of key autophagy-related proteins, including ATG4A, GLIPR2, P62, and LC3. DISCUSSION: Our study provides novel mechanistic insights into how HSYA confers cardioprotection against MI/R injury, highlighting its clinical potential by demonstrating that its effects are mediated at least in part through the modulation of platelet energy metabolism and autophagy. CONCLUSION: HSYA alleviates MI/R injury by inhibiting platelet activation, which is associated with the restoration of mitochondrial function and the modulation of autophagy in platelets.

Current Pharmaceutical BiotechnologyVol. 27
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Harbin University of Commerce (CN)
Openalex Percentile: Top 12%
Sunflower and Safflower Cultivation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.